Conmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral
April 24, 2015 8:19 AM EDTLadenburg Thalmann downgraded CONMED (NASDAQ: CNMD) from Buy to Neutral with a price target of $55 (unchanged).
For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.
Shares of CONMED closed at $54.23 yesterday.
... More


